Prolastin: Clinical Trials

5 trials of Prolastin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 4 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 33Completed 2, Terminated 1

Follow Prolastin: new trials by email Literature Review of Prolastin trials Research Report on Prolastin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19
Prolastin, Standard Medical Treatment - COVID-19
Phase 2CompletedInstituto Grifols, S.A.1002020-07-292021-07-08
Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
α1 Proteinase Inhibitor, Placebos - HIV Disease
Phase 2 / Phase 3TerminatedInstitute for Human Genetics and Biochemistry122012-04-012020-08-31
Therapy to Elevate CD4 Counts in HIV-1 Disease
alpha-1-Proteinase Inhibitor - HIV Disease
Phase 2 / Phase 3CompletedInstitute for Human Genetics and Biochemistry42006-12-012021-09-28
The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
alpha-1 proteinase inhibitor (human) - Alpha 1-Antitrypsin Deficiency
Phase 3CompletedGrifols Therapeutics LLC382006-06-012014-08-19
Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE)
Alpha1-Proteinase Inhibitor (Human), Albumin (Human) 20%, United States Pharmacopeia (USP) - Alpha 1-Antitrypsin Deficiency
Phase 2CompletedGrifols Therapeutics LLC772003-12-012014-08-21

Conditions studied

Acquired Immunodeficiency Syndrome (2)  ·  alpha 1-Antitrypsin Deficiency (2)  ·  COVID-19 (1)  ·  Congenital lobar emphysema (1)  ·  Pulmonary Emphysema (1)

Sponsors

Grifols Therapeutics LLC (2)  ·  Institute for Human Genetics and Biochemistry (2)  ·  Instituto Grifols, S.A. (1)

Countries

United States (3)  ·  United Kingdom (2)  ·  Denmark (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Asger Dirksen, MD PHD (1)  ·  Cynthia Bristow, PhD (1)  ·  Cynthia L Bristow, PhD (1)  ·  Jose Cortes, MD (1)  ·  Kim Hanna, MSc (1)

Results publications

PMID 31824943, PMID 19196813, PMID 19251783, PMID 19483042, PMID 19678952, PMID 20920370, PMID 21617168, PMID 23226015, PMID 24229737